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Diego J Maselli* and Antonio AnzuetoChronic obstructive pulmonary disease (COPD) has sig-
nificant morbidity, major impact on health care costs [1]
and is the 3rd leading cause of death in the United States
[2-4]. The impact becomes greater as the disease pro-
gresses, and is mainly due to the development of acute
exacerbations and need for hospitalizations [5]. Preventing
COPD exacerbations has been a main focus in the treat-
ment of COPD patients. Patients admitted to the hospital
for COPD exacerbation are at a higher risk of re-
hospitalization and death [6-8]. COPD also increases the
hospitalization rate and in-hospital mortality from other
co-morbidities [9]. Several therapeutic options including
the use of inhaled corticosteroids, long acting bronchodila-
tors, phosphodiesterase inhibitors, pulmonary rehabilita-
tion services, and prolonged antibiotic use have been
showed to reduced the incidence of these events [5, 10].
Identifying risk factors for hospitalizations have important
health care implications, but the knowledge of these is
limited.
In this issue of Multidisciplinary Respiratory Medicine,
García-Sanz et al. [11] reported a prospective observational
study conducted in their Emergency Department to deter-
mine the frequency of COPD exacerbations, and factors
associated with hospitalization. These investigators reported
409 exacerbations in 239 patients (79% male, mean age
75 years); 57% of exacerbations required hospitalization.
There were several differences between hospitalized and
non-hospitalized patients including history of prior exacer-
bations, COPD disease severity, use of concomitant medica-
tions such as inhaled and systemic corticosteroids, beta-
blockers and antibiotics. In the multivariate logistic regres-
sion analysis the factors associated with hospitalization were
impaired oxygenation (p<0.001), increased white blood
cells (p<0.01) and prescribed antibiotics (p<0.05).
This study provides insight into factors associated with
hospitalizations for COPD exacerbations in patients that* Correspondence: masellicacer@uthscsa.edu
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distribution, and reproduction in any mediumare evaluated in an emergency room. The study was car-
ried out in a single center and therefore the results may be
difficult to generalize to other institutions. It is possible
that some inherent limitations hampered the ability to find
significant differences in several clinical parameters and
outcomes. For example, several of the differences in vari-
ables between both groups were not significant in the
multivariate logistic regression analysis. Some of the
results reported in this study are consistent with large co-
hort publications. For example, patients with prior history
of hospitalizations and more severe lung disease were
more likely to required hospitalization. These data are
similar to the reports by Hurst et al. [5] and Tsoumakidou
M. et al. [12], and provide useful clinical data when these
patients are evaluated in the emergency department. This
study provides practitioners with other useful clinical data
that is routinely collected in patients with a severe COPD
exacerbation evaluated in the emergency department, such
as oxygenation parameters (PaO2/FiO2 index), and white
blood cell counts. COPD severity based on lung function
(GOLD stage) was shown to also predicted the risk of
hospitalization in COPD for other conditions like pneu-
monia [4]. Therefore, in this study, patients with a suspi-
cious underlying infectious process, elevated white blood
cell count and worsening oxygenation were prescribed
antibiotics and were more likely to be hospitalized. It will
be interesting if the investigators could provide additional
data, such as patients co-morbid conditions, concomitant
medications, radiological findings if a chest radiograph
was obtained and complications developed during
hospitalization. Nevertheless, the data presented by Gar-
cia-Sanz et al. [11] will help to design prospective clinical
studies and interventions related to decrease COPD
exacerbations related hospitalizations.
Because of the fragile condition of these patients and con-
comitant morbidity associated with COPD exacerbations,
the identification of clinical parameters that indicate
patient’s need for hospitalization will have a significant clin-
ical impact. Providing effective clinical care by using routine
clinical data represents a new perspective of the overallCentral Ltd. This is an Open Access article distributed under the terms of the
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http://www.mrmjournal.com/content/7/1/7management of these complex patients. The current study
by Garcia- Sanz et al. [11], taken together with existing data
from other large observations cohorts, highlights the need
to challenge commonly used clinical parameters to make a
decision when to hospitalize patients with COPD exacerba-
tions. In our opinion, further clinical studies are needed to
help in the management of this critical condition and
should take into consideration the results of these
investigators.
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